WebMay 12, 2024 · Curis Reports Updated Data in Two Abstracts for CA-4948 Accepted for Presentation at the European Hematology Association 2024 Virtual Congress /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a... WebDecontaminate with Confidence. Creating healthy facilities is easier, faster, and safer than ever: CURIS decontamination system uses low-level 7% hydrogen to effectively …
Curis Announces Closing of Public Offering of Common Stock …
WebMar 31, 2024 · Nº 58/2024 : 31 March 2024. Information Significant amendments to the Rules of Procedure of the General Court of the European Union will come into force on 1 April. bg es cs da de et el en fr hr ga it lv lt hu mt nl pl pt ro sk sl fi sv. Nº 57/2024 : 30 March 2024. Opinion of the Advocate General in the case C-106/22 Xella Magyarország. WebAs part of the collaboration with Aurigene, in October 2015, Curis exclusively licensed a program of orally-available, small molecule inhibitors of IRAK4 kinase, including … shut down after 1 hour windows 10
Curis Receives FDA Orphan Drug Designation for CA-4948 for …
WebDec 14, 2024 · The securities in the Offering were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-224627) that was filed with the United States Securities and Exchange Commission ... WebJan 6, 2024 · FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2024 Curis, Inc. (Exact name of registrant as specified in charter) Registrant’s telephone number, including area code: (617) 503-6500 Not Applicable WebMay 12, 2024 · Curis, Inc. May 12, 2024, 16:01 ET LEXINGTON, Mass., May 12, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development of innovative therapeutics for... shut down advanced options